Port implantation-related bloodstream infection caused by Wickerhamomyces myanmarensis : A case report
Copyright: © 2021, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center..
Background and Purpose: Wickerhamomyces myanmarensis is a new opportunistic yeast previously named Pichai myanmarensis, which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of W. myanmarensis has been reported from Myanmar, and one clinical sample from Iran.
Case Report: We report a case of bloodstream infection related to an implantable venous access port. W. myanmarensis was isolated from patient's blood after chemotherapy, which was meant to control and heal T-cell lymphoblastic lymphoma. Broth dilution minimum inhibitory concentrations were performed according to the CLSI M27-A3 document. The patient recovered with intravenous voriconazole and was discharged with the recommended prescription of oral voriconazole as a maintenance drug.
Conclusion: So far, only one case of W. myanmarensis fungemia has been reported in the world in 2019. This is the second case of bloodstream infection with this yeast from a patient undergoing chemotherapy in Iran.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Current medical mycology - 9(2023), 1 vom: 10. März, Seite 32-35 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aminasnafi, Ali [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bloodstream infections |
---|
Anmerkungen: |
Date Revised 31.10.2023 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.18502/CMM.2023.150671 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363599037 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM363599037 | ||
003 | DE-627 | ||
005 | 20231226093705.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.18502/CMM.2023.150671 |2 doi | |
028 | 5 | 2 | |a pubmed24n1211.xml |
035 | |a (DE-627)NLM363599037 | ||
035 | |a (NLM)37867594 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aminasnafi, Ali |e verfasserin |4 aut | |
245 | 1 | 0 | |a Port implantation-related bloodstream infection caused by Wickerhamomyces myanmarensis |b A case report |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 31.10.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright: © 2021, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center. | ||
520 | |a Background and Purpose: Wickerhamomyces myanmarensis is a new opportunistic yeast previously named Pichai myanmarensis, which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of W. myanmarensis has been reported from Myanmar, and one clinical sample from Iran | ||
520 | |a Case Report: We report a case of bloodstream infection related to an implantable venous access port. W. myanmarensis was isolated from patient's blood after chemotherapy, which was meant to control and heal T-cell lymphoblastic lymphoma. Broth dilution minimum inhibitory concentrations were performed according to the CLSI M27-A3 document. The patient recovered with intravenous voriconazole and was discharged with the recommended prescription of oral voriconazole as a maintenance drug | ||
520 | |a Conclusion: So far, only one case of W. myanmarensis fungemia has been reported in the world in 2019. This is the second case of bloodstream infection with this yeast from a patient undergoing chemotherapy in Iran | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Bloodstream infections | |
650 | 4 | |a Voriconazole | |
650 | 4 | |a Wickerhamomyces myanmarensis | |
700 | 1 | |a Khodavaisy, Sadegh |e verfasserin |4 aut | |
700 | 1 | |a Moslem, Maryam |e verfasserin |4 aut | |
700 | 1 | |a Esmaeilpour Jouneghani, Marziye |e verfasserin |4 aut | |
700 | 1 | |a Sarbandi, Fatemeh |e verfasserin |4 aut | |
700 | 1 | |a Falahatinejad, Mahsa |e verfasserin |4 aut | |
700 | 1 | |a Bashardoust, Bahareh |e verfasserin |4 aut | |
700 | 1 | |a Badali, Hamid |e verfasserin |4 aut | |
700 | 1 | |a Kiasat, Neda |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medical mycology |d 2015 |g 9(2023), 1 vom: 10. März, Seite 32-35 |w (DE-627)NLM273575279 |x 2423-3439 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2023 |g number:1 |g day:10 |g month:03 |g pages:32-35 |
856 | 4 | 0 | |u http://dx.doi.org/10.18502/CMM.2023.150671 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2023 |e 1 |b 10 |c 03 |h 32-35 |